Clinical trial
A Study of 3 Doses of Dextofisopam in Females With Irritable Bowel Syndrome
NCT00486876 · Pharmos, Industry · Completed
Key facts
| NCT number | NCT00486876 |
|---|---|
| Title | A Study of 3 Doses of Dextofisopam in Females With Irritable Bowel Syndrome |
| Official title | A Double-Blind, Randomized, Placebo-Controlled Phase 2b Study of 100, 200, and 300 mg BID Dextofisopam in Female Outpatients With Irritable Bowel Syndrome |
| Lead sponsor | Pharmos, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Irritable Bowel Syndrome |
| Intervention type | Drug |
| Interventions | Dextofisopam |
| Enrollment | 324 |
| Start date | Jun 1, 2007 |
| Primary completion | Sep 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Jun 15, 2007 |
| Last update posted | Aug 2, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: